Vacuum-Assisted Breast Biopsy Device Market Size, Share, Growth Analysis, By Procedure(Tethered, Untethered), By Product(Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles), By Type(9-12G, <9G, <12G), By Technique(Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), By End User(Hospitals, Academic, Research Institutes, Diagnostic), By Region - Industry Forecast 2024-2031

Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 726.81 million in 2019 and is poised to grow from USD 811.85 million in 2023 to USD 2197.62 million by 2031, growing at a CAGR of 11.7% in the forecast period (2024-2031).

The response time of vacuum-assisted breast biopsy (VABB) is faster than that of other diagnostic devices. The rising prevalence of breast cancer is driving the growth of the vacuum-assisted breast biopsy market. Because of their ability to obtain large amounts of tissues with contiguous specimens, the ability to obtain multiple specimens with single needle insertion, a more accurate diagnosis with a lower cancer miss rate, and lower histological underestimates, vacuum-assisted breast biopsy (VABB) devices are gaining popularity over traditional biopsy methods.

Breast cancer is one of the most common diseases afflicting women in both developed and developing countries. Breast cancer is the second-leading cause of cancer-related deaths in women worldwide, according to the American Cancer Society. The rising number of breast cancer cases has compelled governments around the world to raise awareness about the importance of early detection, which is expected to drive vacuum-assisted breast biopsy device market growth.

US Vacuum-Assisted Breast Biopsy Device Market is poised to grow at a sustainable CAGR for the next forecast year.